Elderly patients with symptoms of heart failure and increased concentrations in the blood of the biomarker copeptin, or a combination of elevated concentrations of copeptin and the biomarker NT-proBNP, had an associated increased risk of all-cause death, according to a new study.

Source: Certain biomarkers appear to increase risk of death for elderly patients with heart failure symptoms


David Cottle

UBB Owner & Administrator